Examining breast cancer disparities in African Americans with suggestions for policy
ST Pellom, T Arnold, M Williams, VL Brown… - Cancer Causes & …, 2020 - Springer
… This review also addresses health policy changes that may … chromosomal abnormalities,
and tumor suppressor and other … , and low to no expression of ESR1, PGR, ERBB2, and …
and tumor suppressor and other … , and low to no expression of ESR1, PGR, ERBB2, and …
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
JJ Harding, J Fan, DY Oh, HJ Choi, JW Kim… - The Lancet …, 2023 - thelancet.com
… as ERBB2)-amplified treatment-refractory biliary tract cancer. … assessment of HER2 status
by in-situ hybridisation and immunohistochemistry assays. HER2 gene amplification status was …
by in-situ hybridisation and immunohistochemistry assays. HER2 gene amplification status was …
Targeted immunotherapy for HER2-low breast cancer with 17p loss
… frequent chromosome abnormalities in breast cancer and … We evaluated a number of
TNBC cell lines (MDA-MB-453, … erb-b2 receptor tyrosine kinase 2 (ERBB2), further drug safety …
TNBC cell lines (MDA-MB-453, … erb-b2 receptor tyrosine kinase 2 (ERBB2), further drug safety …
[HTML][HTML] Molecular mechanisms of feline cancers
J Lin, V Kouznetsova, I Tsigelny - OBM Genetics, 2021 - lidsen.com
… tumors, though mast cell tumors were also investigated in this review. … in genes such as TP53,
ERBB2, and TWIST1 in feline … Feline mammary carcinoma has been proposed as a model …
ERBB2, and TWIST1 in feline … Feline mammary carcinoma has been proposed as a model …
Potential diagnostic and prognostic biomarkers for breast cancer: A compiled review
… ERBB2; formerly HER2) and estrogen or progesterone receptor molecular markers are used
to classify breast cancer … is linked to some kind of abnormality or disease. Tumor marker is …
to classify breast cancer … is linked to some kind of abnormality or disease. Tumor marker is …
Cancer of the breast
… refer a breast cancer patient for genetic evaluation, including … or effects of genes located
nearby on chromosome 17 may also … (C) Gene cluster showing the ERBB2 oncogene and other …
nearby on chromosome 17 may also … (C) Gene cluster showing the ERBB2 oncogene and other …
[HTML][HTML] … , open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with …
MA Shah, D Cunningham, JP Metges… - … of cancer, 2021 - ncbi.nlm.nih.gov
… for stratification (PD-L1) and to evaluate the association of exploratory systemic and/or
tissue-… to HER2 status (A), TMB according to HER2 status (B), correlation between ERBB2 gene …
tissue-… to HER2 status (A), TMB according to HER2 status (B), correlation between ERBB2 gene …
Stromal p53 regulates breast cancer development, the immune landscape, and survival in an oncogene-specific manner
… TP53 alterations in CAFs, with no TP53 abnormalities detected in adjacent tumor cells (17). …
We next evaluated the collaboration between stromal p53 and mammary epithelial ErbB2 …
We next evaluated the collaboration between stromal p53 and mammary epithelial ErbB2 …
Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer
C Francavilla, CS O'Brien - Open Biology, 2022 - royalsocietypublishing.org
… of breast developmental abnormalities or cancer progression. … co-target, which will be
explored in depth in this review. … subtypes, in addition to available data on the status of the gene …
explored in depth in this review. … subtypes, in addition to available data on the status of the gene …